Hyperactivity Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
Conditions:   ADHD;   ADHD - Combined Type;   Attention Deficit Hyper Activity;   Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorder With Hyperactivity;   Attention Deficit Hyperactivity Disorder Combined;   Attention-deficit Hyperactivity Interventions:   Drug: CTx-1301 - Dexmethylphenidate 6.25mg;   Drug: CTx-1301 - Dexmethylphenidate 12.5mg;   Drug: CTx-1301 - Dexmethylphenidate 18.75mg;   Drug: CTx-1301 - Dexmethylphenidate 25.0mg;   Drug: CTx-1301 - Dexmethylphenidate 31.25mg;   Drug: CTx-1301 - Dexmethylphenidate  37.5mg;   Drug: Placebo Spo...
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials